micro2MACRO
A bioprinting platform for the rapid, reliable, controlled and quantifiable patterning of cellular aggregates and microtissues into macroscale regenerative grafts with programmable architectures
About m2M
The main goal of micro2MACRO (m2M) is to develop a new bioprinting platform capable of spatially patterning cellular aggregates or microtissues into scaled-up, personalised durable load-bearing grafts and guiding their (re)modelling into fully functional tissues in vivo within damaged or diseased environments.
m2M will last for 48 months and brings together leading academic institutions, research centers, and companies to create a system for producing personalised, scalable grafts that can support the repair of damaged tissues.
Our objectives
1.
To develop an automated platform for the high-throughput generation of phenotypically distinct microtissues (μTs) in a robust and reproduceable manner.
2.
To design and build sensor-equipped micro-extrusion and inkjet printheads capable of real-time monitoring of bioink properties, including cellularity (i.e., cell or μT number) and shape fidelity.
3.
4.
5.
6.
To prepare for rapid market introduction and clinical uptake of the bioprinted implants by developing a detailed exploitation and regulatory strategy in collaboration with market parties.
7.
We’re pleased to present the latest collaboration between our partners from at
The University of Helsinki, a key collaborator in our ongoing efforts, recently
Regenerative Medicine Utrecht, our partners in the m2M framework, have recently published
